Allogene Therapeutics

Filed a patent for "methods of detection for engineered cells" on Tue, June 20, 2023

Filed a patent for "claudin 18.2 targeting chimeric antigen receptors and binding agents" on Mon, November 28, 2022

Filed a patent for "methods for detecting genomic abnormalities in cells" on Wed, December 7, 2022

Filed a patent for "cd70 anti-idiotype antibodies" on Wed, December 14, 2022

Filed a patent for "methods for donor cell analysis" on Fri, February 24, 2023

Filed a patent for "chimeric switch receptors for the conversion of immunesuppressive signals to costimulatory signals" on Wed, March 22, 2023

Filed a patent for "methods for donor cell analysis" on Thu, December 21, 2023

Filed a patent for "engineered cells with reduced gene expression to mitigate immune cell recognition" on Tue, June 20, 2023

Filed a patent for "method for inhibiting adventitious viral infection" on Fri, June 23, 2023

Filed a patent for "engineered cells with reduced gene expression to mitigate immune cell recognition" on Thu, February 8, 2024

Filed a patent for "method for inhibiting adventitious viral infection" on Thu, March 14, 2024

Filed a patent for "mab-driven chimeric antigen receptor systems for sorting/depleting engineered immune cells" on Thu, July 11, 2024

Filed a patent for "claudin 18.2 targeting chimeric antigen receptors and binding agents" on Mon, October 16, 2023

Filed a patent for "b-cell maturation antigen (bcma) anti-idiotypic antibodies" on Mon, September 19, 2022

Filed a patent for "chimeric switch receptors for the conversion of immunesuppressive signals to costimulatory signals" on Tue, March 29, 2022

Filed a patent for "methods for donor cell analysis" on Thu, April 28, 2022

Filed a patent for "methods for detecting genomic abnormalities in cells" on Thu, June 9, 2022

Filed a patent for "selective targeting of host cd70+ alloreactive cells to prolong allogeneic car t cell persistence" on Fri, June 10, 2022

Filed a patent for "engineered cells with reduced gene expression to mitigate immune cell recognition" on Fri, July 29, 2022

Filed a patent for "method for inhibiting adventitious viral infection" on Tue, August 16, 2022